Brind.

A study enrolling patients across European locations was underway, involving Novo Nordisk and its senior vice president, Filip Knop.

Novo Nordisk presented data at the EASD congress held in Vienna, Austria.

1 report, 1 independent Updated Sep 5

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Novo Nordisk presented data at the EASD congress held in Vienna, Austria.

Who's involved

What this event is mainly about

Novo Nordisk Austria

Keep exploring

Part of

A study enrolling patients across European locations was underway, involving Novo Nordisk and its senior vice president, Filip Knop. All 1 developments

The entities involved

Related events

Coverage

Newest first; wire copies grouped

Sep 5GlobeNewswireNovo Nordisk to present new semaglutide data on ‘food noise’, body composition and cardiovascular benefits, as well as pipeline data at the EASD diabetes congress The INFORM real-world evidence study